Balance Sheet Haleon plc

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 08:36:24 19/09/2024 BST			5-day change	1st Jan Change
394.20 ^GBX	-0.66%		+2.14%	+23.02%

09-16	Haleon Picks PubMatic as Supply Partner for Media Buying	MT
09-13	Deutsche Bank cuts AstraZeneca to 'sell'	AN

1af.gtV0ugOMkiFUqJwcfjUvye4zDQ6JxVQkzhAh1E1Dh4M.sIpBjGHJ5hURn_tpKQ1IjYtwbH3rggZcpGAUnAwOytzo4D_5ZPWjVR6Q9w

Published financial data: HALEON PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	8.48B	9.89B	9.54B	10.86B	11.3B
Total Revenues	8.48B	9.89B	9.54B	10.86B	11.3B
Cost of Goods Sold, Total	3.24B	3.76B	3.56B	4.13B	4.34B
Gross Profit	5.24B	6.13B	5.98B	6.73B	6.96B
Selling General & Admin Expenses, Total	3.36B	3.84B	3.92B	4.04B	4.29B
R&D Expenses	267M	296M	256M	303M	297M
Other Operating Expenses	-	-	-	-7M	17M
Other Operating Expenses, Total	3.63B	4.14B	4.18B	4.33B	4.6B
Operating Income	1.61B	2B	1.81B	2.4B	2.36B
Interest Expense, Total	-30M	-22M	-16M	-278M	-414M
Interest And Investment Income	24M	18M	17M	56M	25M
Net Interest Expenses	-6M	-4M	1M	-222M	-389M
Currency Exchange Gains (Loss)	3M	29M	-	-	-
Other Non Operating Income (Expenses)	-8M	-32M	-38M	223M	-90M
EBT, Excl. Unusual Items	1.6B	1.99B	1.77B	2.4B	1.88B
Restructuring Charges	-330M	-411M	-195M	-41M	-40M
Merger & Related Restructuring Charges	-366M	-91M	-	-8M	-2M
Gain (Loss) On Sale Of Assets	-17M	212M	31M	24M	-10M
Asset Writedown	-	-	-5M	-137M	-191M
Other Unusual Items	-	-66M	35M	-619M	-9M
EBT, Incl. Unusual Items	886M	1.63B	1.64B	1.62B	1.63B
Income Tax Expense	199M	410M	197M	499M	517M
Earnings From Continuing Operations	687M	1.22B	1.44B	1.12B	1.11B
Net Income to Company	687M	1.22B	1.44B	1.12B	1.11B
Minority Interest	-32M	-36M	-49M	-59M	-62M
Net Income - (IS)	655M	1.19B	1.39B	1.06B	1.05B
Net Income to Common Incl Extra Items	655M	1.19B	1.39B	1.06B	1.05B
Net Income to Common Excl. Extra Items	655M	1.19B	1.39B	1.06B	1.05B
Per Share Items
Net EPS - Basic	-	-	0.15	0.11	0.11
Basic EPS - Continuing Operations	-	-	0.15	0.11	0.11
Basic Weighted Average Shares Outstanding	-	-	9.23B	9.24B	9.23B
Net EPS - Diluted	-	-	0.15	0.11	0.11
Diluted EPS - Continuing Operations	-	-	0.15	0.11	0.11
Diluted Weighted Average Shares Outstanding	-	-	9.23B	9.24B	9.26B
Normalized Basic EPS	-	-	0.11	0.16	0.12
Normalized Diluted EPS	-	-	0.11	0.16	0.12
Dividend Per Share	-	2.37K	-	0.02	0.06
Payout Ratio	175.88	199.75	82.59	253.02	36.99
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	1.8B	2.21B	1.99B	2.58B	2.55B
EBITA	1.64B	2.05B	1.85B	2.44B	2.4B
EBIT	1.61B	2B	1.81B	2.4B	2.36B
EBITDAR	1.8B	2.21B	1.99B	-	-
Effective Tax Rate - (Ratio)	22.46	25.11	12.04	30.84	31.76
Total Current Taxes	217M	551M	311M	437M	539M
Total Deferred Taxes	-18M	-141M	-114M	62M	-22M
Normalized Net Income	967M	1.21B	1.06B	1.44B	1.11B
Interest on Long-Term Debt	4M	7M	4M	4M	5M
Non-Cash Pension Expense	3M	-7M	-6M	2M	2M
Supplemental Operating Expense Items
Advertising Expense	1.77B	2.01B	1.94B	2.03B	2.02B
Selling and Marketing Expenses	-	-	-	-	2.02B
Research And Development Expense From Footnotes	292M	304M	257M	300M	311M
Net Rental Expense, Total	1M	1M	1M	-	-
Imputed Operating Lease Interest Expense	-	312K	173K	-	-
Imputed Operating Lease Depreciation	-	688K	827K	-	-
Stock-Based Comp., SG&A Exp. (Total)	58M	63M	59M	61M	-
Stock-Based Comp., Other (Total)	-	-	-	-	88M
Total Stock-Based Compensation	58M	63M	59M	61M	88M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	340M	334M	414M	684M	1.04B
Total Cash And Short Term Investments	340M	334M	414M	684M	1.04B
Accounts Receivable, Total	1.4B	1.35B	1.32B	1.49B	1.35B
Other Receivables	1.13B	1.16B	995M	378M	483M
Notes Receivable	1.46B	1.12B	1.51B	6M	5M
Total Receivables	3.99B	3.63B	3.82B	1.87B	1.84B
Inventory	1.21B	949M	951M	1.35B	1.41B
Prepaid Expenses	29M	61M	56M	106M	107M
Other Current Assets, Total	237M	74M	5M	50M	419M
Total Current Assets	5.81B	5.05B	5.25B	4.06B	4.82B
Gross Property Plant And Equipment	2.72B	2.74B	2.77B	3.1B	3.16B
Accumulated Depreciation	-1.1B	-1.14B	-1.11B	-1.2B	-1.26B
Net Property Plant And Equipment	1.62B	1.6B	1.66B	1.9B	1.9B
Long-term Investments	-	-	-	-	65M
Goodwill	8.17B	8.26B	8.25B	8.4B	8.32B
Other Intangibles, Total	19.84B	18.95B	18.95B	20.04B	18.54B
Deferred Tax Assets Long-Term	254M	251M	312M	220M	265M
Other Long-Term Assets, Total	13M	51M	31M	201M	150M
Total Assets	35.71B	34.17B	34.45B	34.82B	34.06B
Liabilities
Accounts Payable, Total	1.9B	1.83B	1.58B	1.84B	1.86B
Accrued Expenses, Total	930M	836M	751M	467M	559M
Short-term Borrowings	481M	348M	874M	393M	60M
Current Portion of Long-Term Debt	-	-	-	31M	548M
Current Portion of Leases	40M	34M	30M	44M	48M
Current Income Taxes Payable	196M	236M	202M	210M	288M
Unearned Revenue Current, Total	7M	11M	11M	23M	21M
Other Current Liabilities	717M	722M	791M	1.37B	1.26B
Total Current Liabilities	4.27B	4.01B	4.24B	4.37B	4.64B
Long-Term Debt	-	-	1M	10.06B	8.86B
Long-Term Leases	121M	105M	87M	117M	89M
Pension & Other Post Retirement Benefits	298M	336M	253M	161M	157M
Deferred Tax Liability Non Current	3.51B	3.37B	3.36B	3.6B	3.49B
Other Non Current Liabilities	97M	79M	35M	48M	92M
Total Liabilities	8.3B	7.91B	7.97B	18.36B	17.33B
Common Stock, Total	1M	1M	1M	92M	92M
Additional Paid In Capital	20.84B	-	-	-	-
Retained Earnings	5.11B	37.8B	37.99B	26.73B	27.47B
Comprehensive Income and Other	1.37B	-11.65B	-11.63B	-10.49B	-10.96B
Total Common Equity	27.32B	26.15B	26.36B	16.33B	16.61B
Minority Interest	91M	111M	125M	126M	123M
Total Equity	27.41B	26.26B	26.48B	16.46B	16.73B
Total Liabilities And Equity	35.71B	34.17B	34.45B	34.82B	34.06B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	9.23B	9.23B	9.23B
ECS Total Common Shares Outstanding	-	-	9.23B	9.23B	9.23B
Book Value / Share	-	-	2.85	1.77	1.8
Tangible Book Value	-691M	-1.06B	-840M	-12.1B	-10.25B
Tangible Book Value Per Share	-	-	-0.09	-1.31	-1.11
Total Debt	642M	487M	992M	10.65B	9.61B
Net Debt	302M	153M	578M	9.96B	8.56B
Debt Equivalent of Unfunded Proj. Benefit Obligation	178M	182M	142M	52M	-64M
Debt Equivalent Oper. Leases	8M	8M	8M	-	-
Minority Interest, Total (Incl. Fin. Div)	91M	111M	125M	126M	123M
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Raw Materials, Total	240M	231M	233M	310M	298M
Inventories - Work In Process, Total	147M	70M	47M	35M	20M
Inventories - Finished Goods, Total	824M	648M	671M	1B	1.09B
Land - (BS)	925M	904M	914M	927M	967M
Machinery, Total	1.43B	1.44B	1.46B	1.65B	1.7B
Full Time Employees	-	21.9K	22.8K	24.62K	25.41K
Accumulated Allowance for Doubtful Accounts (Supple)	35M	51M	53M	41M	29M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	655M	1.19B	1.39B	1.06B	1.05B
Depreciation & Amortization - CF	198M	215M	174M	180M	201M
Amortization of Goodwill and Intangible Assets - (CF)	27M	50M	40M	43M	39M
Depreciation & Amortization, Total	225M	265M	214M	223M	240M
Amortization of Deferred Charges, Total - (CF)	35M	40M	54M	64M	69M
(Gain) Loss From Sale Of Asset	11M	-209M	-31M	-30M	12M
Asset Writedown & Restructuring Costs	12M	88M	1M	143M	200M
Stock-Based Compensation (CF)	-	-	-	-	76M
Other Operating Activities, Total	309M	63M	-120M	422M	561M
Change In Accounts Receivable	-57M	18M	14M	-85M	38M
Change In Inventories	232M	130M	-17M	-292M	-131M
Change In Accounts Payable	-256M	140M	41M	387M	112M
Change in Other Net Operating Assets	-380M	-315M	-190M	171M	-126M
Cash from Operations	786M	1.41B	1.36B	2.06B	2.1B
Capital Expenditure	-190M	-222M	-228M	-304M	-234M
Sale of Property, Plant, and Equipment	51M	6M	12M	-	-
Cash Acquisitions	120M	20M	-	-	-71M
Divestitures	-	221M	-	-	-
Sale (Purchase) of Intangible assets	67M	828M	67M	12M	144M
Investment in Marketable and Equity Securities, Total	219M	158M	100M	700M	-
Other Investing Activities, Total	24M	19M	16M	-9.19B	27M
Cash from Investing	291M	1.03B	-33M	-8.78B	-134M
Long-Term Debt Issued, Total	1M	38M	8M	11B	-
Total Debt Issued	1M	38M	8M	11B	-
Long-Term Debt Repaid, Total	-42M	-54M	-38M	-1.56B	-608M
Total Debt Repaid	-42M	-54M	-38M	-1.56B	-608M
Issuance of Common Stock	335M	-	4M	18M	-
Repurchase of Common Stock	-	-	-	-	-38M
Common Dividends Paid	-1.15B	-2.37B	-1.15B	-2.68B	-388M
Common & Preferred Stock Dividends Paid	-1.15B	-2.37B	-1.15B	-2.68B	-388M
Other Financing Activities, Total	-67M	-50M	-62M	134M	-534M
Cash from Financing	-925M	-2.44B	-1.24B	6.91B	-1.57B
Foreign Exchange Rate Adjustments	-14M	-6M	-5M	15M	-15M
Net Change in Cash	138M	-6M	82M	205M	383M
Supplemental Items
Cash Interest Paid	29M	19M	15M	163M	404M
Cash Income Tax Paid (Refund)	309M	554M	310M	324M	445M
Levered Free Cash Flow	-	2.85B	824M	3.43B	1.17B
Unlevered Free Cash Flow	-	2.86B	834M	3.6B	1.43B
Change In Net Working Capital	-	-639M	461M	-2.05B	348M
Net Debt Issued / Repaid	-41M	-16M	-30M	9.44B	-608M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	3.57	3.29	4.33	4.28
Return on Total Capital	-	4.55	4.17	5.49	5.52
Return On Equity %	-	4.56	5.46	5.21	6.7
Return on Common Equity	-	4.44	5.3	4.97	6.37
Margin Analysis
Gross Profit Margin %	61.76	61.99	62.69	61.97	61.59
SG&A Margin	39.62	38.82	41.08	37.16	37.94
EBITDA Margin %	21.27	22.37	20.81	23.79	22.56
EBITA Margin %	19.3	20.68	19.35	22.48	21.22
EBIT Margin %	18.99	20.18	18.93	22.08	20.87
Income From Continuing Operations Margin %	8.1	12.36	15.08	10.31	9.83
Net Income Margin %	7.72	12	14.56	9.76	9.28
Net Avail. For Common Margin %	7.72	12	14.56	9.76	9.28
Normalized Net Income Margin	11.41	12.2	11.08	13.27	9.85
Levered Free Cash Flow Margin	-	28.78	8.64	31.58	10.39
Unlevered Free Cash Flow Margin	-	28.92	8.74	33.18	12.68
Asset Turnover
Asset Turnover	-	0.28	0.28	0.31	0.33
Fixed Assets Turnover	-	6.14	5.85	6.1	5.95
Receivables Turnover (Average Receivables)	-	7.21	7.16	7.74	7.96
Inventory Turnover (Average Inventory)	-	3.48	3.75	3.59	3.15
Short Term Liquidity
Current Ratio	1.36	1.26	1.24	0.93	1.04
Quick Ratio	0.67	0.71	0.64	0.58	0.62
Operating Cash Flow to Current Liabilities	0.18	0.35	0.32	0.47	0.45
Days Sales Outstanding (Average Receivables)	-	50.78	50.97	47.15	45.84
Days Outstanding Inventory (Average Inventory)	-	105.13	97.37	101.61	115.86
Average Days Payable Outstanding	-	194.88	174.46	137.66	153.02
Cash Conversion Cycle (Average Days)	-	-38.97	-26.11	11.1	8.69
Long Term Solvency
Total Debt/Equity	2.34	1.85	3.75	64.69	57.42
Total Debt / Total Capital	2.29	1.82	3.61	39.28	36.48
LT Debt/Equity	0.44	0.4	0.33	61.85	53.5
Long-Term Debt / Total Capital	0.43	0.39	0.32	37.55	33.99
Total Liabilities / Total Assets	23.24	23.14	23.14	52.73	50.88
EBIT / Interest Expense	53.67	90.73	112.94	8.63	5.7
EBITDA / Interest Expense	61.17	102.77	126.31	9.43	6.28
(EBITDA - Capex) / Interest Expense	54.83	92.68	112.06	8.33	5.71
Total Debt / EBITDA	0.35	0.22	0.49	4.06	3.7
Net Debt / EBITDA	0.16	0.07	0.29	3.8	3.29
Total Debt / (EBITDA - Capex)	0.39	0.24	0.55	4.59	4.06
Net Debt / (EBITDA - Capex)	0.18	0.08	0.32	4.3	3.62
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	16.65	-3.51	13.76	4.09
Gross Profit, 1 Yr. Growth %	-	17.09	-1.87	12.45	3.45
EBITDA, 1 Yr. Growth %	-	22.67	-6.36	14.09	-0.31
EBITA, 1 Yr. Growth %	-	24.98	-5.48	14.87	-0.75
EBIT, 1 Yr. Growth %	-	23.98	-5.09	15.01	-0.59
Earnings From Cont. Operations, 1 Yr. Growth %	-	78.02	21.85	-22.24	-0.72
Net Income, 1 Yr. Growth %	-	81.22	21.4	-23.74	-1.04
Normalized Net Income, 1 Yr. Growth %	-	24.78	-6.56	17.01	-21.88
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-23.74	-1.55
Accounts Receivable, 1 Yr. Growth %	-	-3.51	-2.23	12.82	-9.08
Inventory, 1 Yr. Growth %	-	-21.64	0.21	41.75	4.45
Net Property, Plant and Equip., 1 Yr. Growth %	-	-1.17	3.75	14.26	0.16
Total Assets, 1 Yr. Growth %	-	-4.31	0.94	1.06	-2.18
Tangible Book Value, 1 Yr. Growth %	-	53.98	-24.05	1.34K	-15.33
Common Equity, 1 Yr. Growth %	-	-4.27	0.93	-38.03	1.68
Cash From Operations, 1 Yr. Growth %	-	79.01	-3.62	52.14	1.79
Capital Expenditures, 1 Yr. Growth %	-	16.84	2.7	33.33	-23.03
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-70.88	249.85	-66.06
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-70.67